Clinical Trials for Elevar Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Elevar Therapeutics

Clinical Trials (1)

NCT04526106
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
490 participants
Started: Sep 2, 2020 · Completed: Dec 31, 2027
8 conditions1 sponsor48 locations